Subscribe To
2 super stocks set to join apple, microsoft, amazon, alphabet, and nvidia in the $1 trillion club
Warren Buffett's Berkshire Hathaway is a top candidate to cross the trillion-dollar threshold. Meta Pla...
September 15, 2023, 5:35 am
Bp will consider external candidates for ceo; chair rules himself out of the running
BP PLC (LSE:BP.) is considering both internal and external candidates in its search for a new chief exe...
September 15, 2023, 2:31 am
Nektar (nktr) up on positive new data from eczema study
Nektar (NKTR) gains on positive new data for its pipeline candidate, rezpegaldesleukin, evaluated from ...
September 14, 2023, 9:01 am
Okyo pharma announces share offering
OKYO Pharma Ltd (NASDAQ:OKYO) has announced a public offering of its shares with the net proceeds to fund the clinical development of its product
September 13, 2023, 4:33 pm
Uaw strike: these ford, gm plants are the most likely targets
The UAW is considering a break with tradition, moving to targeted strikes at specific Ford Motor Co., General Motors Co. and Stellantis NV plants, and...
September 13, 2023, 1:41 pm
Exelixis (exel) gets rights for tumor candidate from insilico
Exelixis (EXEL) enters into a license agreement with Insilico Medicine for ISM3091, a potentially best-in-class USP1 inhibitor....
September 13, 2023, 12:46 pm
Acelyrin (slrn) fails to meet goal in hs study, stock down 54%
ACELYRIN (SLRN) fails to achieve statistically significant primary endpoint result in the hidradenitis suppurativa study of its lead ...
September 13, 2023, 11:16 am
“bear market leader”? here’s a prime candidate
This stock market sector has failed to recover since the Dow’s Q1 correction By Elliott Wave International As you may know, in every bull or bear ma...
September 12, 2023, 4:55 pm
Arbutus (abus) to focus on hepatitis b candidates, stock up
Arbutus (ABUS) makes a strategic decision to focus on the development of hepatitis B virus therapies while discontinuing all coronavirus and oral RNA ...
September 12, 2023, 10:36 am
Curevac signals progress on mrna flu vaccine
CureVac NV CVAC, -3.85% said Tuesday that it has selected an mRNA flu vaccine candidate for continued c...
September 12, 2023, 8:05 am
“bear market leader”? here’s a prime candidate
By Elliott Wave International As you may know, in every bull or bear market, some stocks or sector lead while others follow. So, the “leadership” ...
September 12, 2023, 6:49 am
Why shares of eyepoint pharmaceuticals were rising monday
EyePoint reported top-line data on two phase 2 trials for its lead pipeline candidate. The company focu...
September 11, 2023, 3:20 pm
Adding zymeworks to my value watchlist (initial buy rating)
Zymeworks is a biotech company focused on developing therapies for hard-to-treat cancers. Its lead product, zanidatamab, has shown promising results i...
September 11, 2023, 3:06 am
Dyne therapeutics: muscle disease oligo therapy developer in early stages
Dyne Therapeutics is developing treatments for genetically driven muscle diseases, focusing on Myotonic Dystrophy Type 1 (DM1) and Duchenne Muscular D...
September 10, 2023, 5:25 am
Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13
Management will present and hold virtual 1-on-1 meetings with institutional investors and analysts BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) ...
September 8, 2023, 6:30 pm
Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13
BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology compa...
September 8, 2023, 2:30 pm
Semiconductor check: buy the dip in these highly ranked stocks
In terms of price-to-earnings valuation, these semiconductor stocks are very attractive relative to their past and rising EPS estimates indicate they ...
September 8, 2023, 2:17 pm
Syndax pharmaceuticals: positive axatilimab phase 2 results
Syndax is making strides in the adoption of entinostat, a cancer therapeutic used in combination with immune checkpoint therapies. Syndax reported an ...
September 8, 2023, 10:42 am
International wide-moat stocks on sale - the september 2023 heat map
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in ...
September 7, 2023, 9:05 pm
Lumos pharma announces participation in investor conferences in september
AUSTIN, Texas, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic ...
September 7, 2023, 4:34 pm